Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10872486 | 0.82 | CYP3A4 (0.42) | HSD17B10TSHRCYP3A4PIK3CARECQL | |
| SCHEMBL3789127 | 0.79 | LIPG (0.34) | LIPGHSD17B10TSHRENPP2ALDH1A1 | |
| SCHEMBL3792751 | 0.79 | TSHR (0.36) | HSD17B10TSHRCYP3A4PIK3CAALOX15 | |
| SCHEMBL3781543 | 0.74 | LIPG (0.33) | LIPGHSD17B10TSHRALOX15ENPP2 | |
| SCHEMBL3790582 | 0.73 | ALDH1A1 (0.47) | HSD17B10TSHRCYP3A4PIK3CARECQL | |
| SCHEMBL3783955 | 0.73 | SLC6A4 (0.35) | TSHRALOX15ENPP2KDM4EALDH1A1 | |
| SCHEMBL3802412 | 0.72 | ALDH1A1 (0.50) | HSD17B10TSHRCYP3A4PIK3CARECQL | |
| SCHEMBL3781848 | 0.71 | LIPG (0.36) | LIPGHSD17B10TSHRCYP3A4PIK3CA | |
| Alcohol SCHEMBL29246863 | 0.70 | ENPP2 (0.45) | LIPGHSD17B10TSHRCYP3A4ALOX15 | |
| SCHEMBL3785266 | 0.69 | ALDH1A1 (0.50) | HSD17B10RECQLALOX15KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | LIPG 3010/4885HSD17B10 1100/4885TSHR 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.